Search Results

You are looking at 1 - 10 of 1,479 items for :

Clear All
Open access

Helen Hughes, Vikram Swaminathan, Alice Pellegrini and Riccardo Audisio

elderly. Oncology (Williston Park) 2006;20(2):135-43. [5] De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014;15:23-34. [6] Department of Health. The impact of patient age on decision making in oncology. Department of Health, 2012. www.gov.uk/government/publications/the-impact-of-patient-age-on-clinical-decision-making-in-oncology. [7] Kimmick G, Fleming ST, Sabatino SA, Wu XC, Hwang W, Wilson JF et al. Centers for

Open access

Moretti Luigi

case for mitomycin in non-small cell lung cancer. Oncology 1993;50 Suppl 1:35-50. 17. Kemp C. Metastatic spread and common symptoms. Part One: Introduction, bladder cancer, and brain cancer. Am J Hosp Palliat Care 1998;15:355-60. 18. Kemp C. Breast cancer, colorectal cancer, and esophageal cancer. Am J Hosp Palliat Care 1999;16:403-11. 19. Kemp C. Kidney cancer, leukemia, and liver cancer. Part 3. Am J Hosp Palliat Care 1999;16:479-86. 20. Walsh TD, West TS. Controlling symptoms in advanced cancer. Br

Open access

Marija Zivkovic Radojevic, Marko Folic and Slobodan Jankovic

ABBREVIATIONS OP - oncology patients QAFRT - questionnaire for assessment fear of radiotherapy RT - radiotherapy VAS - visual analogue scale REFERENCES 1. Andersen BL, Tewfik HH. Psychological reactions to radiation therapy: reconsideration of the adaptive aspects of anxiety. J Pers Soc Psychol 1985;48(4):1024-32. 2. Peck A, Boland J. Emotional reactions to radiation treatment. Cancer 1977;40(1):180-4. 3. Krischer MM, Xu P, Meade CD, Jacobsen PB. Self-administered stress management training in pa-tients undergoing radiotherapy. J

Open access

Mario Ciliberto, Fabio Maggi, Giorgio Treglia, Federico Padovano, Lucio Calandriello, Alessandro Giordano and Lorenzo Bonomo

for the staging and follow-up of patients with metastasis. Eur J Radiol 2009; 70: 393-400. 5. Lambregts DM, Maas M, Cappendijk VC, Prompers LM, Mottaghy FM, Beets GL, et al. Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer staging. Eur J Cancer 2011; 47: 2107-16. 6. Thomson V, Pialat JB, Gay F, Coulon A, Voloch A, Granier A, et al. Wholebody MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between

Open access

Sara Prijic and Gregor Sersa

thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 2007; 81: 53-60. FDA-Approved Drugs [Internet]. Boston (MA): CenterWatch. 1995 - . FDA Approved Drugs for Oncology [cited 2010 September 14]; [about 7 p.]. Available from: http://www.centerwatch.com/drug-information/fda-approvals/drug-areas.aspx?AreaID=12 Widder KJ, Morris RM, Poore GA, Howard DP, Senyei AE. Selective targeting of magnetic albumin

Open access

Andrea Obročníková and Ľudmila Majerníková

REFERENCES/PIŚMIENNICTWO 1. Dennison CR. The role of patient-reported outcomes in evaluating the quality of oncology care. Am J Manag Care. 2002;8 (18 Suppl):580–586. 2. Pešek J. Tvorba systému jakosti ve zdravotníctví a lékárenství s využitím norem ISO. 1. vyd. Praha: Grada Publising; 2003, p.110. 3. Ganz PA. What outcomes matter to patients: a physician-researcher point of view. Med Care. 2002;40(6Suppl):III11–19. 4. Labarere J, Francois P, Auquier P, et al. Development of a french inpatient satisfaction questionnaire. International J

Open access

Alexandru C. Grigorescu

advanced cancer: is it worth it? Aust Prescr 2000;23:80-2. 8. Kumar A, Soares H, Balducci L, Djulbegovic B. Treatment tolerance and efficacy in geriatric oncology: A systematic review of phase III randomized trials conducted by five National Cancer Institutesponsored cooperative groups. J Clin Oncol 2007;25:1272-6. 9. Shenoy C1, Klem I, Crowley AL, Patel MR, Winchester MA, Owusu C, et al. Cardiovascular Complications of Breast Cancer Therapy in Older Adults. Oncologist 2011;11:1138-43. 10. Goldhirsch A, Colleoni M, Coates

Open access

Christos Emmanouilides

References [1] COLLIER R. Drug development cost estimates hard to swallow. Canadian Med Assoc J, 2009, 180:279-280 [2] DIMASI JA, GRABOWSKI HG. Economics of new oncology drug development. J Clin Oncol 2007, 25:209-216 [3] ΚΑΡΑΜΠΛΗ Ε, ΧΑΤΖΑΚΗ Α, ΠΟΛΥΖΟΣ Ν, ΣΟΥΛΙΩΤΗΣ Κ, ΚΥΡΙΟΠΟΥΛΟΣ Γ. Η επίδραση της τεχνολογικής αλλαγής στη διαχρονική εξέλιξη της δαπάνης υγείας. Αρχ Ελλην Ιατρ 2014, 31:77-84 [4] WHO-International Agency for Research on Cancer. http://eco.iarc.fr/EUCAN/Country.aspx?ISOCountryCd=300 [5] Εθνικό σχέδιο δράσης για τον

Open access

Momir Polenakovic and Zivko Popov

Abstract

The 5th Uro-oncology Winter Congress was held in Skopje, at the Macedonian Academy of Sciences and Arts on January 30 - February 03, 2013. The Congress was co-organized by the Macedonian Academy of Sciences and Arts, the Istanbul University, the Turkish Urology Association, Macedonian Society of Urology and the Ministry of Health of the Republic of Macedonia. Topics of the Congress were tumors of urinary tract (kidney, vesica urinaria) and prostate. The latest achievements in the diagnosis and treatment of the above-mentioned disease were presented. Around 300 participants from the Balkans took part at the meeting. There were simultaneous sessions on different uro-oncological issues with around 60 presentations. In addition, there were poster presentations and training courses. It is important to point out that we had a session with participation of Balkan uro-oncologists - Balkan Urology Session, which is the first time in recent years.

Open access

Christopher A. Barker, Maria Chang, Kathryn Beal and Timothy A. Chan

, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993; 85: 704-10. 6. Mehta MP, Siker ML, Chakravarti A. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? Crit Rev Oncol Hematol 2006; 60: 99-111. 7. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide